Post-Transplant Cyclophosphamide versus Methotrexate based Regimen as Graft Versus Host Disease prophylaxis after Allogeneic Haematopoietic Stem Cell Transplantation in patients with Acute Leukemia
Calcineurin inhibitor (CNI) and methotrexate (MTX) are used as standard GVHD prophylaxis in HSCT. Trials using High dose Post-transplant Cyclophosphamide (PT-Cy) with or without immunosuppressive agents (IS) have shown success. However, further studies are needed. To compare clinical outcomes of all...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Series: | Hematology Reports |
| Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8906 |